海外研报
筛选
Reiterate Buy rating (on Conviction List) on Potential for Positive EPS Revisions and Compelling
We reiterate our Buy rating on NVDA (also on the Conviction List)ahead of FY2Q (July) results scheduled for August 28 (post market
海外研报
2024年08月20日
GS--India Pharma: Aug’24 Pulse Check: Export tracker
We analyse the export data of key CRDMO companies for Aug’24 to get the senseof the latest trends in the market. At a company-specific level, the current month’s
海外研报
2024年09月16日
